Lithium sulphate - Karo Pharma

Drug Profile

Lithium sulphate - Karo Pharma

Alternative Names: Lithionit

Latest Information Update: 21 Dec 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator BioPhausia
  • Developer Karo Pharma AB
  • Class Alkali metals; Antidepressants; Antimanics; Antipsychotics; Light metals
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Manic episodes

Most Recent Events

  • 21 Dec 2016 Chemical structure information added
  • 26 Jan 2001 Swedish Medical Products Agency approves lithium sulphate for Manic episodes (In patients with Bipolar disorders) in Sweden (PO, 83mg)
  • 14 Nov 1997 Launched for Manic episodes in Norway (PO) after November 1997
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top